Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 13 July 2001:
Vol. 293. no. 5528, pp. 234 - 235
DOI: 10.1126/science.293.5528.234
Prev | Table of Contents | Next

News

Driving a Stake Into Resurgent TB

Martin Enserink

Eighty years after the first tuberculosis vaccine was developed from a bovine cousin of Mycobacterium tuberculosis, the bacterium that causes the disease, its efficacy has come into question. Health leaders have been saying they need a new vaccine; now a fascinating conjunction of events has led to trials of at least five new TB vaccines. But who will pay for them?

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Construction of a eukaryotic expression system for granulysin and its protective effect in mice infected with Mycobacterium tuberculosis..
B. Liu, S. Liu, X. Qu, and J. Liu (2006)
J. Med. Microbiol. 55, 1389-1393
   Abstract »    Full Text »    PDF »
A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary Tuberculosis.
M. A. Horwitz and G. Harth (2003)
Infect. Immun. 71, 1672-1679
   Abstract »    Full Text »
Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test by Using Respiratory and Nonrespiratory Specimens in a Tertiary Care Center Laboratory.
C. E. O'Sullivan, D. R. Miller, P. S. Schneider, and G. D. Roberts (2002)
J. Clin. Microbiol. 40, 1723-1727
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)